Hybrid Closed-Loop Systems to Date: Hype Versus Reality.

In 2017, the first hybrid closed-loop (HCL) system entered the market, sparking hope for a diabetes care revolution: "Eliminate hypoglycemia!" A framework for optimizing technology-enabled diabetes and cardiometabolic care and education: The role of the diabetes care and education specialist. Evidence suggests that regardless of the HCL system, strengthening I:C ratios helps to improve glycemic outcomes.[[29], [31]] All HCL systems use total daily insulin to scale insulin adjustments to varying degrees. Diabetes care is a marathon, not a sprint, and choosing the HCL system that will promote consistent enduring wear is the best choice for the person with diabetes. [Extracted from the article]